0001250853-23-000046.txt : 20230801 0001250853-23-000046.hdr.sgml : 20230801 20230801153726 ACCESSION NUMBER: 0001250853-23-000046 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230801 DATE AS OF CHANGE: 20230801 EFFECTIVENESS DATE: 20230801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC. CENTRAL INDEX KEY: 0001335105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202903526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-488474 FILM NUMBER: 231131397 BUSINESS ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 BUSINESS PHONE: 310 203 2902 MAIL ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 FORMER COMPANY: FORMER CONFORMED NAME: SRKP 7 INC DATE OF NAME CHANGE: 20050803 D 1 primary_doc.xml X0708 D LIVE 0001335105 LIXTE BIOTECHNOLOGY HOLDINGS, INC. 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 11733 6318307092 DELAWARE SRKP 7 INC Corporation true John Kovach 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Executive Officer Director James Miser 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Executive Officer Robert Weingarten 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Executive Officer Eric Forman 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Executive Officer Stephen Forman 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Director Regina Brown 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Director Yun Yen 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Director Rene Bernards 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Director Bas van der Baan 680 East Colorado Boulevard Suite 180 Pasadena CA CALIFORNIA 91101 Director Biotechnology Decline to Disclose 06b false 2023-07-20 false true false 3500000 A.G.P. / ALLIANCE GLOBAL PARTNERS 8361 None None 88 POST ROAD WEST 2ND FLOOR WESTPORT CT CONNECTICUT 06880 NY NEW YORK false 3500000 3500000 0 The common stock warrants being offered hereunder are being offered as part of a broader offering which includes the public sale of shares of common stock and pre-funded warrants. The total offering amount is $3,500,000. false 1 210000 0 0 false LIXTE BIOTECHNOLOGY HOLDINGS, INC. /s/ John S. Kovach John S. Kovach Chief Executive Officer 2023-08-01